Q Zuo, Q Xu, Z Li, D Luo, H Peng, Z Duan - Anti-Cancer Drugs, 2023 - journals.lww.com
Oxaliplatin (OXA) is a standard agent for colorectal cancer (CRC) adjuvant chemotherapy.
However, acquired and intrinsic OXA resistance is a primary challenge for CRC treatment …